Trial intelligence / Profile preview

Pneumococcal vaccination in rheumatoid arthritis patients receiving immunomodulatory therapy

2014-001299-79Phase 3Completed

Sponsor
University Hospital Odense
Start
Jul 2014
Modality
Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, open-label trial of pneumococcal 7-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease (2 arms), sponsored by University Hospital Odense. Started Jul 2014; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03

Conditions

pneumococcal disease

Beyond the preview

Go deeper on 2014-001299-79.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-001299-79.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call